Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
The system for delivery into a XCR1 positivity cell, and its use
Document Type and Number:
Japanese Patent JP5946494
Kind Code:
B2
Abstract:
The present invention relates to a delivery system suitable for delivering a substance into a XCR1 positive professional antigen-presenting cell, one or more nucleic acids coding for the same, a vector comprising the nucleic acid(s), a medicament comprising the delivery system or the one or more nucleic acid(s) and an adjuvant comprising XCL1 or a functionally active fragment thereof.

Inventors:
Crocek Richard
Application Number:
JP2014150090A
Publication Date:
July 06, 2016
Filing Date:
July 23, 2014
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
Bundes Republik Germany Land Let's Bartleten Darch das Robert Kosh-Institut Bartleten Darch Seinen Pradenten
International Classes:
A61K47/48; A61K39/00; A61K39/39; A61K47/42; A61P31/00; A61P35/00; A61P37/06; A61P37/08
Domestic Patent References:
JP2001526240A
Other References:
石井 保之,免疫制御リボソームによる根本的治療,別冊・医学のあゆみ 上気道アレルギー疾患研究,2007年 3月,第59-63頁
HSPを用いた免疫増強とHLA消失による免疫回避,医学のあゆみ,2007年 5月,第221巻,第8号,第627-630頁
赤木 隆美,高分子ナノ微粒子を用いるワクチンの開発,日本臨牀,2006年,第64巻,第2号,第279-285頁
東 市郎,合成免疫アジュバントの開発とMDP-抗原結合ワクチン,日本臨牀,遠藤 武男,1987年,第45巻,第10号,第155-161頁
Lymphotactin gene-modified bone marrow dendritic cells act as more potent adjuvants for peptide delivery to induce specific antitumor immunity. ,Journal of immunology,Vol.161,No.11,1998年,pp.6238-44.
Attorney, Agent or Firm:
Hatsushi Shimizu
Masao Haruna
Hirotaka Yamaguchi
Toshi Gobe
Ryuichi Inoue
Toshimitsu Sato
Koichi Niimi
Tomohiko Kobayashi
Masato Ozeki
Yoshihiro Igarashi
Kazuya Kawamoto



 
Previous Patent: Pinball machine

Next Patent: HEAT EXCHANGER OF SILICON CARBIDE